Clinical Signs of Hepatic Encephalopathy
Hepatic encephalopathy presents with a spectrum of neuropsychiatric and motor abnormalities ranging from subtle cognitive deficits detectable only on psychometric testing to overt disorientation, asterixis, and coma. 1
Mental and Cognitive Manifestations
The earliest signs affect attention, working memory, psychomotor speed, and visuospatial ability that may only be detected through formal psychometric testing (covert HE). 1 As the condition progresses, you will observe:
- Personality changes: apathy, irritability, disinhibition reported by family members 1
- Sleep-wake disturbances: excessive daytime sleepiness (complete reversal is less common than traditionally taught) 1
- Progressive disorientation: first to time, then to space 1
- Inappropriate behavior and acute confusional states: with either agitation or somnolence 1
- Stupor progressing to coma in severe cases 1
The onset of disorientation or asterixis marks the transition to overt HE according to ISHEN consensus. 1
Motor System Abnormalities
Pyramidal Signs
In non-comatose patients, look for:
- Hypertonia and hyper-reflexia 1
- Positive Babinski sign 1
- Paradoxically, deep tendon reflexes may diminish or disappear while pyramidal signs persist 1
- Transient focal neurological deficits (rare) 1
- Seizures are very rarely reported 1
Extrapyramidal Dysfunction
Common findings include:
- Hypomimia (reduced facial expression) 1
- Muscular rigidity 1
- Bradykinesia and hypokinesia 1
- Monotony and slowness of speech 1
- Parkinsonian-like tremor 1
- Dyskinesia with diminished voluntary movements 1
Asterixis ("Flapping Tremor")
This is the most characteristic motor sign, present in early to middle stages before stupor or coma. 1 Key features:
- Not actually a tremor but a negative myoclonus (loss of postural tone) 1
- Elicited by hyperextension of wrists with separated fingers or rhythmic squeezing of examiner's fingers 1
- Can also be observed in feet, legs, arms, tongue, and eyelids 1
- Not pathognomonic—also occurs in uremia and other metabolic encephalopathies 1
Critical Diagnostic Pitfalls
Mental and motor signs do not necessarily progress in parallel in individual patients, making severity staging challenging. 1 This is crucial because you cannot rely on a uniform progression pattern.
Special Variants to Recognize
Hepatic myelopathy: severe motor abnormalities (paraplegia, progressive spasticity, weakness of lower limbs, hyper-reflexia) that exceed mental dysfunction, related to long-standing portosystemic shunting, unresponsive to standard ammonia-lowering therapy. 1
Cirrhosis-associated parkinsonism: prominent extrapyramidal signs with brain atrophy, occurs in approximately 4% of advanced liver disease cases, also unresponsive to ammonia-lowering therapy. 1
Essential Differential Diagnosis
In 22% of patients with liver disease suspected of having HE, the cause is actually extrahepatic. 2 You must systematically exclude:
- Infections: urinary tract infection, pneumonia, meningitis, encephalitis 2
- Perfusion disorders: stroke, myocardial infarction 2
- Intracranial bleeding: subdural hematoma 2
- Metabolic derangements: hypo/hyperglycemia, hyponatremia, renal dysfunction, hypothyroidism 2
- Substance-related: alcohol intoxication, psychoactive drugs 2
- Thiamine deficiency and malnutrition 2
- Non-convulsive seizures (requires EEG) 2
Covert HE vs. Mild Cognitive Impairment (MCI)
There is significant overlap between covert HE and MCI in patients over 60 years (MCI prevalence up to 20% in this age group). 2 Key distinguishing features:
Covert HE characteristics:
- Deficits in attention, concentration, visuospatial orientation, motor speed and accuracy 2
- Language preserved 2
- Memory preserved 2
- Severe daily functional impairment 2
- Often fluctuating 2
MCI characteristics:
- Memory dysfunction or alterations in complex attention, executive function, learning, language, perceptual-motor function 2
- Daily functioning largely preserved 2
- Usually noticeable for at least 6 months 2
- Alteration of motor speed and accuracy not typical 2
The strong EASL 2022 recommendation is to identify alternative or additional causes of neuropsychiatric impairment in all suspected HE cases, as this improves prognostic accuracy and treatment outcomes. 2